ORMP
Oramed Pharmaceuticals Inc
NASDAQ: ORMP · HEALTHCARE · BIOTECHNOLOGY
$3.88
+1.04% today
Updated 2026-04-30
Market cap
$163.00M
P/E ratio
2.69
P/S ratio
81.50x
EPS (TTM)
$1.50
Dividend yield
—
52W range
$2 – $4
Volume
0.1M
Oramed Pharmaceuticals Inc (ORMP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
3,202.00%
Operating margin
-754.00%
ROE
37.10%
ROA
-4.88%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-414576.00 | — | — | — |
| 2007 | — | $-3.24M | — | — | — |
| 2008 | — | $-2.77M | — | — | — |
| 2009 | — | $-2.76M | — | — | — |
| 2010 | — | $-2.98M | — | — | — |
| 2011 | $197412.00 | $-1.56M | 100.00% | -1,233.60% | -790.86% |
| 2012 | $184254.00 | $-3.34M | 100.00% | 1,565.24% | -1,815.15% |
| 2013 | — | $-4.23M | — | — | — |
| 2014 | — | $-5.70M | — | — | — |
| 2015 | — | $-7.23M | — | — | — |
| 2016 | $641000.00 | $-10.96M | 23.56% | -1,561.62% | -1,710.45% |
| 2017 | $2.46M | $-10.48M | 92.39% | -438.56% | -426.71% |
| 2018 | $2.45M | $-12.73M | 96.49% | -552.35% | -519.68% |
| 2019 | $2.70M | $-14.36M | 96.67% | -541.29% | -531.08% |
| 2020 | $2.71M | $-11.51M | 96.68% | -433.84% | -424.76% |
| 2021 | $2.70M | $-22.24M | 100.00% | -896.15% | -822.72% |
| 2022 | $2.70M | $-37.76M | 100.00% | -1,501.96% | -1,397.11% |
| 2023 | $1.34M | $5.53M | 100.00% | -1,176.79% | 412.31% |
| 2024 | $0.00 | $-19.10M | — | — | — |
| 2025 | $2.00M | $75.32M | 0.65% | -754.40% | 3,766.20% |